149 related articles for article (PubMed ID: 36361816)
21. An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes.
Thiemeyer H; Taher L; Schille JT; Packeiser EM; Harder LK; Hewicker-Trautwein M; Brenig B; Schütz E; Beck J; Nolte I; Murua Escobar H
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768937
[TBL] [Abstract][Full Text] [Related]
22. In vitro model of metastasis to bone marrow mediates prostate cancer castration resistant growth through paracrine and extracellular matrix factors.
Lescarbeau RM; Seib FP; Prewitz M; Werner C; Kaplan DL
PLoS One; 2012; 7(8):e40372. PubMed ID: 22870197
[TBL] [Abstract][Full Text] [Related]
23. Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.
Cho WJ; Oliveira DS; Najy AJ; Mainetti LE; Aoun HD; Cher ML; Heath E; Kim HR; Bonfil RD
J Transl Med; 2016 Mar; 14():72. PubMed ID: 26975354
[TBL] [Abstract][Full Text] [Related]
24. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
25. Identification of Transcriptional Markers and microRNA-mRNA Regulatory Networks in Colon Cancer by Integrative Analysis of mRNA and microRNA Expression Profiles in Colon Tumor Stroma.
Uddin MN; Li M; Wang X
Cells; 2019 Sep; 8(9):. PubMed ID: 31500382
[TBL] [Abstract][Full Text] [Related]
26. Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
Chen S; Chen Y; Zhu Z; Tan H; Lu J; Qin P; Xu L
Int J Med Sci; 2020; 17(9):1269-1280. PubMed ID: 32547322
[No Abstract] [Full Text] [Related]
27. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
28. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
29. Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer.
Berglund AE; Rounbehler RJ; Gerke T; Awasthi S; Cheng CH; Takhar M; Davicioni E; Alshalalfa M; Erho N; Klein EA; Freedland SJ; Ross AE; Schaeffer EM; Trock BJ; Den RB; Cleveland JL; Park JY; Dhillon J; Yamoah K
Prostate Cancer Prostatic Dis; 2019 May; 22(2):292-302. PubMed ID: 30367117
[TBL] [Abstract][Full Text] [Related]
30. Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment.
Morrissey C; Brown LG; Pitts TE; Vessella RL; Corey E
Neoplasia; 2010 Feb; 12(2):192-205. PubMed ID: 20126477
[TBL] [Abstract][Full Text] [Related]
31. Cross-platform comparison of immune-related gene expression to assess intratumor immune responses following cancer immunotherapy.
Zhang L; Cham J; Cooley J; He T; Hagihara K; Yang H; Fan F; Cheung A; Thompson D; Kerns BJ; Fong L
J Immunol Methods; 2021 Jul; 494():113041. PubMed ID: 33753096
[TBL] [Abstract][Full Text] [Related]
32. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
[TBL] [Abstract][Full Text] [Related]
33. Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression.
Mangiola S; McCoy P; Modrak M; Souza-Fonseca-Guimaraes F; Blashki D; Stuchbery R; Keam SP; Kerger M; Chow K; Nasa C; Le Page M; Lister N; Monard S; Peters J; Dundee P; Williams SG; Costello AJ; Neeson PJ; Pal B; Huntington ND; Corcoran NM; Papenfuss AT; Hovens CM
BMC Cancer; 2021 Jul; 21(1):846. PubMed ID: 34294073
[TBL] [Abstract][Full Text] [Related]
34. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA‑512‑3p is upregulated, and promotes proliferation and cell cycle progression, in prostate cancer cells.
Rao Z; He Z; He Y; Guo Z; Kong D; Liu J
Mol Med Rep; 2018 Jan; 17(1):586-593. PubMed ID: 29115469
[TBL] [Abstract][Full Text] [Related]
36. Correlation of NTRK1 Downregulation with Low Levels of Tumor-Infiltrating Immune Cells and Poor Prognosis of Prostate Cancer Revealed by Gene Network Analysis.
Bagherabadi A; Hooshmand A; Shekari N; Singh P; Zolghadri S; Stanek A; Dohare R
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627227
[TBL] [Abstract][Full Text] [Related]
37. Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment.
Vardaki I; Corn P; Gentile E; Song JH; Madan N; Hoang A; Parikh N; Guerra L; Lee YC; Lin SC; Yu G; Santos E; Melancon MP; Troncoso P; Navone N; Gallick GE; Efstathiou E; Subudhi SK; Lin SH; Logothetis CJ; Panaretakis T
Clin Cancer Res; 2021 Jun; 27(11):3253-3264. PubMed ID: 33753455
[TBL] [Abstract][Full Text] [Related]
38. Identification of Potential Key Genes and Pathways in Enzalutamide-Resistant Prostate Cancer Cell Lines: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database.
Zheng L; Dou X; Ma X; Qu W; Tang X
Biomed Res Int; 2020; 2020():8341097. PubMed ID: 32724813
[TBL] [Abstract][Full Text] [Related]
39. Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.
Mazzu YZ; Armenia J; Nandakumar S; Chakraborty G; Yoshikawa Y; Jehane LE; Lee GM; Atiq M; Khan N; Schultz N; Kantoff PW
Mol Oncol; 2020 Aug; 14(8):1881-1897. PubMed ID: 32385899
[TBL] [Abstract][Full Text] [Related]
40. Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice.
Furesi G; de Jesus Domingues AM; Alexopoulou D; Dahl A; Hackl M; Schmidt JR; Kalkhof S; Kurth T; Taipaleenmäki H; Conrad S; Hofbauer C; Rauner M; Hofbauer LC
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
